Biohaven Ltd.
BHVN
$15.61
$0.936.34%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -766.97M | -888.60M | -846.42M | -804.34M | -746.61M |
| Total Depreciation and Amortization | 8.68M | 8.66M | 7.86M | 7.29M | 6.83M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 84.52M | 248.17M | 239.30M | 256.35M | 263.27M |
| Change in Net Operating Assets | 28.70M | -13.17M | 16.81M | 14.11M | -3.63M |
| Cash from Operations | -645.08M | -644.94M | -582.45M | -526.59M | -480.13M |
| Capital Expenditure | -1.35M | -4.07M | -4.05M | -4.47M | -5.11M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | -391.00K | 0.00 | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -30.39M | -109.67M | -240.93M | -156.74M | -4.16M |
| Cash from Investing | -31.74M | -114.13M | -244.97M | -161.21M | -9.27M |
| Total Debt Issued | 250.00M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 360.59M | 680.40M | 682.23M | 647.37M | 571.01M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -7.17M | -5.68M | -4.46M | 2.79M | -40.88M |
| Cash from Financing | 603.43M | 674.72M | 677.77M | 650.16M | 530.13M |
| Foreign Exchange rate Adjustments | 71.00K | 104.00K | 75.00K | -323.00K | -363.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -73.32M | -84.24M | -149.58M | -37.97M | 40.37M |